Pathophysiology, Risk factors and Management of Chronic Heart Failure, Volume 2

Chronic Heart Failure (CHF) is a complex condition that requires comprehensive management. Volume 2 of "Pathophysiology, Risk Factors, and Management of Chronic Heart Failure" focuses on therapies, management, guidelines, and future advances. It discusses pharmacological therapies, including gene therapy and cell implantation therapy, as well as non-pharmacological therapies such as dietary interventions and physical training. The book also covers the management of patients with heart failure, with detailed guidelines from the International College of Cardiology and future research directions. These volumes serve as essential references for researchers and practicing clinicians, proposing novel methods of research and discussing the need for improved approaches in the management of HF.

Format: Paperback / softback
Length: 410 pages
Publication date: 01 February 2024
Publisher: Elsevier Science Publishing Co Inc

Chronic Heart Failure (CHF) is a complex cardiovascular condition that affects millions of people worldwide. It is characterized by the inability of the heart to pump blood efficiently, leading to symptoms such as shortness of breath, fatigue, and swelling. In this comprehensive two-volume set, Pathophysiology, Risk Factors, and Management of Chronic Heart Failure, Volume 2 aims to provide an in-depth overview of CHF.

The second volume, in particular, focuses on the therapies, management, guidelines, and future advances in heart failure. It explores the uncertainties and challenges in pharmacological therapies, while also introducing a range of new treatment options, including gene therapy, cell implantation therapy, invasive and surgical interventions, and non-pharmacological therapies. These non-pharmacological therapies encompass dietary interventions, holistic approaches, and physical training.

The book delves into the comprehensive management of patients with heart failure, covering various aspects such as diagnosis, treatment, and follow-up. It concludes with detailed and updated guidelines from the International College of Cardiology, as well as future research directions and advancements in the field.

These two separate volumes serve as essential references for both researchers and practicing clinicians. They propose novel methods of research by utilizing behavioral and environmental risk factors as intervention agents, while also discussing the deficiencies in the present approaches to managing HF and proposing new methods for early diagnosis and therapies.

By combining the expertise of leading experts in the field, Pathophysiology, Risk Factors, and Management of Chronic Heart Failure, Volume 2 offers a comprehensive and up-to-date understanding of CHF, providing valuable insights for improving patient outcomes and advancing the field of cardiology.

Dimension: 276 x 215 (mm)
ISBN-13: 9780128229705